Please assess the completion status of the following clinical trial:

Trial Title: NEIVATECH Virtual Reality-based System for Amblyopia

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Children aged between 7 and 15 years.~* VA in the amblyopic eye \< 0.1 logMAR units.~* Interocular difference in VA ≥ 1 logMAR line.~* Interocular difference in espherical equivalent ≥ 1 D.~* Interpupillary distance (IPD) between 60.7 and 73.5 mm.~* Use of best refractive correction for at least 2 months prior to inclusion.~* Lack of response or therapeutic adherence to conventional occlusion therapy.~* Willingness to attend all the active vision therapy sessions and/or visits of the study.~* No history of previous treatment for amblyopia other than optimal refractive correction for at least 2 months prior to inclusion.~Exclusion Criteria:~* Active eye disease.~* Previous ocular surgery.~* BCVA in the amblyopic eye of ≥ 0.70 logMAR.~* Presence of cognitive impairment or neurological or psychiatric disorders.~* Presence of irregular cornea due to astigmatism or ectatic corneal disease.

- Gender: ALL
- Minimum Age: 7 Years
- Maximum Age: 15 Years
- Healthy Volunteers: f

Study Arms:
- Active group (Type: EXPERIMENTAL): 18 half-hour in-office active vision therapy sessions with the NEIVATECH Virtual Reality-based system

Based on this trial design, predict the completion outcome and termination type (if applicable).